However, as the authors refer, there are some cases of cancer cells where arylsulfatases (ARS) are overexpressed (ARSA and ARSB), as in human lung cancer, pertaining to one of the cell lines tested that yielded lower toxicity of extracts, comparatively to fibroblasts. The gene discussed is ARSA; the disease is lung carcinoma.